We are live on
!
Find out more
Compass Therapeutics
CMPX
CMPX
201 hedge funds and large institutions have $919M invested in Compass Therapeutics in 2026 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 75 increasing their positions, 48 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,626% more call options, than puts
Call options by funds: $19.2M | Put options by funds: $1.11M
163% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 19
56% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 48
16% more funds holding
Funds holding: 173 → 201 (+28)
3.91% more ownership
Funds ownership: 92.29% → 96.2% (+3.9%)
4% more capital invested
Capital invested by funds: $881M → $919M (+$37.6M)
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
Holders
201
Holders Change
+28
Holders Change %
+16.18%
% of All Funds
2.48%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.06%
New
50
Increased
75
Reduced
48
Closed
19
Calls
$19.2M
Puts
$1.11M
Net Calls
+$18.1M
Net Calls Change
+$18.1M
Top Buyers
Top Sellers
| 1 |
Blackstone Inc
New York
|
-$24.6M |
| 2 |
Millennium Management
New York
|
-$13.1M |
| 3 |
TECP
Trails Edge Capital Partners
Atlanta,
Georgia
|
-$7.6M |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$7.56M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$6.79M |
